The American people have so far contributed 15 million doses of Covid-19 vaccine to Bangladesh, with the last shipment of 3.5 million doses of the Pfizer vaccine, said the US Embassy in Dhaka today.

The government plans to jab 10 lakh doses daily from next month to ramp up the Covid-19 vaccination campaign which has gathered some pace in recent months following smooth supply of vaccines.

A consignment of two lakh doses of Sinopharm’s Covid-19 vaccine from China reached Dhaka today.

Facebook late on Sunday removed a video by Brazilian President Jair Bolsonaro from its platforms, in which the far-right leader made a false claim that Covid-19 vaccines were linked with developing AIDS.

Moderna said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, as the manufacturer joins its rival Pfizer in moving toward expanding shots to children.

More than 66 lakh people, aged 25 and above, will receive their second dose of Covid-19 vaccines in a special countrywide campaign on Thursday, officials said yesterday.

Children as young as 3 will start receiving Covid-19 vaccines in China, where 76% of the population has been fully vaccinated and authorities are maintaining a zero-tolerance policy toward outbreaks.

Prime Minister Sheikh Hasina today congratulated her Indian counterpart, Narendra Modi, on achieving the historic milestone of administering one billion Covid-19 vaccine doses on October 21 by his government.

Foreign Minister Dr AK Abdul Momen yesterday said there is no shortage of vaccines in Bangladesh, adding that the vaccination drive in the country will go on as planned.

Bangladesh needs to attain self-sufficiency in vaccine supply as soon as possible to combat Covid-19 and any future public health emergencies, Ramon Magsaysay Award winner scientist Dr Firdausi Qadri has said.

Federal health regulators said late Friday that kid-size doses of Pfizer’s COVID-19 vaccine appear highly effective at preventing symptomatic infections in elementary school children and caused no unexpected safety issues, as the U.S. weighs beginning vaccinations in youngsters.

The Pfizer/BioNTech Covid-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the US drugmaker said yesterday.

Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to that age group.

A booster dose of the COVID-19 vaccine developed by Pfizer Inc (PFE.N) and German partner BioNTech SE (22UAy.DE) restored efficacy to 95.6% against the virus, including the Delta variant, data released by the companies from a large study showed on Thursday.

A total of 55 lakh doses of Sinopharm Covid-19 vaccine reached Dhaka from China early today.

The US Food and Drug Administration on Wednesday authorised booster doses of the Covid-19 vaccines from Moderna Inc (MRNA.O) and Johnson & Johnson (JNJ.N), and said Americans can choose a different shot from their original inoculation as a booster.

Children age 5 to 11 will soon be able to get a Covid-19 shot at their pediatrician’s office, local pharmacy and potentially even their school, the White House said Wednesday as it detailed plans for the expected authorisation of the Pfizer shot for younger children in a matter of weeks.

It will be possible to vaccinate at least 50 percent of the target population by December due to the manner in which Covid-19 vaccine is coming to the country according to the government's plan, Health and Family Welfare Minister Zahid Maleque said today.

Around three crore people will get Covid-19 vaccines each month from November, Health Minister Zahid Maleque said yesterday.

Ten lakh jabs of Sinovac’s Covid-19 vaccine has arrived as gift at Hazrat Shahjalal International Airport yesterday.